Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

CX5N:GR

2.745 EUR 0.169 5.80%

As of 13:40:54 ET on 03/03/2015.

Snapshot for CytRx Corp (CX5N)

Open: 2.785 Day's Range: 2.741 - 2.892 Volume: 500
Previous Close: 2.914 52wk Range: 1.661 - 4.439 1-Yr Rtn: -34.64%

Stock Chart for CX5N

No chart data available.
  • CX5N:GR 2.892
  • 1D
  • 1M
  • 1Y
2.914
Interactive CX5N Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CX5N

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.7250
Est. PEG Ratio -
Market Cap (M EUR) 153.00
Shares Outstanding (M) 55.74
30 Day Average Volume 125
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CX5N

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CX5N

CytRx Corporation is a biopharmaceutical research and development company. The Company focuses in the development of high-value human therapeutics, specializing in oncology. CytRx is also developing two drug candidates based on its molecular chaperone regulation technology.

Steven A KriegsmanPresident/CEOJean-Yves Caloz "John"CFO/Treasurer
Joseph RubinfeldChief Scientific AdvisorBenjamin S LevinSenior VP/Gen Counsel/Secretary
More Company Profile & Key Executives for CX5N

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil